Cargando…

Half of germline pathogenic and likely pathogenic variants found on panel tests do not fulfil NHS testing criteria

Genetic testing for cancer predisposition has been curtailed by the cost of sequencing, and testing has been restricted by eligibility criteria. As the cost of sequencing decreases, the question of expanding multi-gene cancer panels to a broader population arises. We evaluated how many additional ac...

Descripción completa

Detalles Bibliográficos
Autores principales:	Andoni, Tala, Wiggins, Jennifer, Robinson, Rachel, Charlton, Ruth, Sandberg, Michael, Eeles, Rosalind
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8861039/ https://www.ncbi.nlm.nih.gov/pubmed/35190596 http://dx.doi.org/10.1038/s41598-022-06376-4

Ejemplares similares

Rare Germline Pathogenic Variants Identified by Multigene Panel Testing and the Risk of Aggressive Prostate Cancer
por: Nguyen-Dumont, Tú, et al.
Publicado: (2021)

Germline multigene panel testing revealed a BRCA2 pathogenic variant in a patient with suspected Lynch syndrome
por: Yoshihama, Tomoko, et al.
Publicado: (2020)

Prevalence of pathogenic germline variants in the circulating tumor DNA testing
por: Yamamoto, Yoshihiro, et al.
Publicado: (2022)

Commensal or pathogen – a challenge to fulfil Koch’s Postulates
por: Hess, M.
Publicado: (2017)

Are patients fulfilling MET criteria recognized?
por: Hesselfeldt, R, et al.
Publicado: (2009)

Germline multigene panel testing of patients with endometrial cancer
por: Kral, Jan, et al.
Publicado: (2023)

Clinical Yield of a Molecular Diagnostic Panel for Enteric Pathogens in Adult Outpatients With Diarrhea and Validation of Guidelines-Based Criteria for Testing
por: Clark, Stephen D, et al.
Publicado: (2019)

Thai patients who fulfilled NCCN criteria for breast/ovarian cancer genetic assessment demonstrated high prevalence of germline mutations in cancer susceptibility genes: implication to Asian population testing
por: Lertwilaiwittaya, Pongtawat, et al.
Publicado: (2021)

Germline Testing and Somatic Tumor Testing for BRCA1/2 Pathogenic Variants in Ovarian Cancer: What Is the Optimal Sequence of Testing?
por: Kwon, Janice S., et al.
Publicado: (2022)

Vae Victis. Prophecy of Non-Panel Practitioners Fulfilled
por: Barton, W. E.
Publicado: (1913)

Potential pathogenic germline variant reporting from tumor comprehensive genomic profiling complements classic approaches to germline testing
por: Tung, Nadine, et al.
Publicado: (2023)

Profile of Pathogenic Mutations and Evaluation of Germline Genetic Testing Criteria in Consecutive Breast Cancer Patients Treated at a North Indian Tertiary Care Center
por: Mittal, Abhenil, et al.
Publicado: (2021)

Multigene Panel Germline Testing of 1333 Czech Patients with Ovarian Cancer
por: Lhotova, Klara, et al.
Publicado: (2020)

Germline genetic profiling in prostate cancer: latest developments and potential clinical applications
por: Ahmed, Mahbubl, et al.
Publicado: (2015)

Transcriptome Analysis in Renal Transplant Biopsies Not Fulfilling Rejection Criteria
por: Moreso, Francesc, et al.
Publicado: (2020)

Serum testosterone and prostate cancer in men with germline BRCA1/2 pathogenic variants
por: Dias, Alexander, et al.
Publicado: (2023)

The contribution of respiratory pathogens to the seasonality of NHS Direct calls
por: Cooper, D.L., et al.
Publicado: (2007)

Expanded PCR Panel Testing for Identification of Respiratory Pathogens and Coinfections in Influenza-like Illness
por: Upadhyay, Pallavi, et al.
Publicado: (2023)

Pathogenic and likely pathogenic variant prevalence among the first 10,000 patients referred for next-generation cancer panel testing
por: Susswein, Lisa R., et al.
Publicado: (2016)

Beyond germline genetic testing - heterozygous pathogenic variants in PMS2 in two children with Osteosarcoma and Ependymoma
por: Kuhlen, Michaela, et al.
Publicado: (2023)

Do Hungarian multiple sclerosis care units fulfil international criteria?
por: Kokas, Zsófia, et al.
Publicado: (2022)

Clinician-Reported Impact of Germline Multigene Panel Testing on Cancer Risk Management Recommendations
por: Horton, Carolyn, et al.
Publicado: (2022)

Detection of germline variants in Brazilian breast cancer patients using multigene panel testing
por: Guindalini, Rodrigo Santa Cruz, et al.
Publicado: (2022)

Universal Germline Panel Testing for Individuals With Pheochromocytoma and Paraganglioma Produces High Diagnostic Yield
por: Horton, Carolyn, et al.
Publicado: (2022)

Next Generation Sequencing-Based Germline Panel Testing for Breast and Ovarian Cancers in Pakistan
por: Tariq, Hassan, et al.
Publicado: (2021)

Pathogenic Characteristics of Microbes Found in Malignant Neoplasms
Publicado: (1890)

Comparison of Multiplex Gastrointestinal Pathogen Panel and Conventional Stool Testing for Evaluation of Patients With HIV Infection
por: Sobczyk, Juliana, et al.
Publicado: (2020)

Multigene testing panels reveal pathogenic variants in sporadic breast cancer patients in northern China
por: Liu, Yinfeng, et al.
Publicado: (2023)

Detection of Germline Mutations in a Cohort of 139 Patients with Bilateral Breast Cancer by Multi-Gene Panel Testing: Impact of Pathogenic Variants in Other Genes beyond BRCA1/2
por: Fanale, Daniele, et al.
Publicado: (2020)

Detection of BRCA1 Pathogenic Variant in a 24-Year-Old Endometrial Cancer Patient: Risks of Several Hereditary Tumor Syndromes Assessed Using Germline Multigene Panel Testing
por: Wang, Xiaofei, et al.
Publicado: (2022)

Correction: Corrigendum: Pathogenic and likely pathogenic variant prevalence among the first 10,000 patients referred for next-generation cancer panel testing
Publicado: (2016)

Nutritional deficits in elderly smokers with respiratory symptoms that do not fulfill the criteria for COPD
por: Obase, Yasushi, et al.
Publicado: (2011)

Prevalence of Germline Pathogenic and Likely Pathogenic Variants in Patients With Second Breast Cancers
por: Yao K, Katharine A, et al.
Publicado: (2020)

The context-specific role of germline pathogenicity in tumorigenesis
por: Srinivasan, Preethi, et al.
Publicado: (2021)

Germline pathogenic variants in 786 neuroblastoma patients
por: Kim, Jung, et al.
Publicado: (2023)

Evaluation of Germline Genetic Testing Criteria in a Hospital-Based Series of Women With Breast Cancer
por: Yadav, Siddhartha, et al.
Publicado: (2020)

Psychosocial outcomes following germline multigene panel testing in an ethnically and economically diverse cohort of patients
por: Culver, Julie O., et al.
Publicado: (2020)

Guideline-Based, Multi-Gene Panel Germline Genetic Testing for at-Risk Patients with Breast Cancer
por: Abdel-Razeq, Hikmat, et al.
Publicado: (2023)

Population-based estimates of breast cancer risk for carriers of pathogenic variants identified by gene-panel testing
por: Southey, Melissa C., et al.
Publicado: (2021)

Cancer Risk Associated With PTEN Pathogenic Variants Identified Using Multigene Hereditary Cancer Panel Testing
por: Cummings, Shelly, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_780hetgt0akh4uji3el1ot5qnk